Publication | Open Access
Identification of GPX4 as a therapeutic target for lung adenocarcinoma after EGFR-TKI resistance
28
Citations
21
References
2022
Year
GPX4 could serve as a novel therapeutic target for EGFR-TKI resistance in LUAD.
| Year | Citations | |
|---|---|---|
Page 1
Page 1